FOSUN INTL (00656): Fosun Pharma's first quarter net profit attributable to shareholders was 27.626 million yuan, a decrease of 27.3% year-on-year.
Fosun International (00656) announced the first quarter performance of Fosun High-tech in 2025, with operating income of approximately 21.553 billion...
FOSUN INTL (00656) announced the performance of Fosun Pharma for the first quarter of 2025, with operating income of approximately 21.553 billion yuan, a year-on-year decrease of 32.9%; the profit attributable to shareholders of the parent company was 27.626 million yuan, a year-on-year decrease of 27.3%.
Related Articles
US Stock Market Move | Uxin Ltd. Sponsored ADR (UXIN.US) surged more than 11%, achieving EBITDA profit for the first time after quarterly adjustments.
New stock news | Teslink updates prospectus with revenue soaring by 83.2%, strategic upgrade aiming for IPO.
New stock news | TersiLian updates its prospectus with last year's revenue reaching 1.843 billion, leading the AIoT market.
US Stock Market Move | Uxin Ltd. Sponsored ADR (UXIN.US) surged more than 11%, achieving EBITDA profit for the first time after quarterly adjustments.
New stock news | Teslink updates prospectus with revenue soaring by 83.2%, strategic upgrade aiming for IPO.
New stock news | TersiLian updates its prospectus with last year's revenue reaching 1.843 billion, leading the AIoT market.
RECOMMEND
Nonfarm payroll data is coming! If there are cracks in the US labor market, the probability of a rate cut by the Federal Reserve in June is expected to increase significantly.
30/04/2025
Under the threat of tariffs, the trade deficit of US goods has reached a historical record! There is a high probability that the GDP will suffer a heavy blow in the first quarter.
30/04/2025
From AI chatting to online shopping, OpenAI is striving to make ChatGPT the "universal application" of the AI era.
29/04/2025
